Clinical Trial Update: Utilization of 31P-Nuclear Magnetic Resonance Spectroscopy to Monitor Brain Energy Deficit in Huntington Disease [NA]

View source ↗

Summary

This clinical trial explored using 31P-NMR spectroscopy to monitor brain energy deficits in Huntington's disease. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Huntington Disease

Snippet

Sponsor: Institut National de la Santé Et de la Recherche Médicale, France | Conditions: Huntington Disease | NA | Status: COMPLETED